Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Targeting Gene Mutation Alleviates Psychosis SymptomsSchizophrenia is an 'umbrella diagnosis,' with many genetic causes. Targeting specific gene mutations may improve psychosis symptoms, potentially paving the way for future personalized medicine.
Framework Ranks 'Actionability' of Genetic MutationsDr David Kerr discusses the use of the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) for determining the level of evidence for actionability of genomic alterations.
